SCAI and HRS have collaborated on new guidelines designed to help clinicians make the safest, smartest treatment decisions possible.

Karen Joynt Maddox, MD, MPH, explained the many ways cardiology's business models are starting to evolve. She also touched on a number of other topics, including AI and the power of prevention.

The first coronary DCB to gain FDA approval just received an additional reimbursement that could improve patient access. 

The minimally invasive operation, known as AVATAR, is performed through a small incision in the patient’s neck.

The interventional device, designed to perform both M-TEER and T-TEER, is at the center of two new studies published in EuroIntervention.

Temporary pacemakers are typically used for at least 24 hours before care teams consider implanting a permanent device. New research out of Canada suggests it may make sense in certain scenarios to go straight to the permanent pacemaker. 

GE Healthcare reports Q2 revenue growth of 3% and lower than expected tariff losses at $550 million.

Researchers expected these conditions to reduce the benefits of early treatment. However, that was not the case.

Cardiologist compensation in the United States is experiencing slow, but steady growth. How does it compare to other specialties? 

The European Society of Cardiology 2025 congress includes 10 Hot Line sessions and 28 late-breaking science sessions to showcase the latest science.